Stephen, my oncologist talked about it last fall but it has not yet received FDA approval. I understand it is designed for advanced metastasized castrate resistant prostate cancer. (I am three years into this struggle and have used bicalutimide, enxalutamide, lupron, zolodronic acid and current I am receiving radium223.) It is along road and Lu177 may be the next treatment option.

How long are you in this struggle? I assume you have metastatic cancer and have exhausted or nearly exhausted other treatment options. Good luck. Stay positive. Stay strong.